Clinical Trials Logo

Clinical Trial Summary

The placenta accreta spectrum (PAS) which includes accreta, increta, and percreta represents a significant obstetric challenge. PAS complicates as many as 1 per 500 pregnancies and this risk is increased with prior cesarean deliveries. Antenatal diagnosis of PAS allows for multidisciplinary planning and delivery before the onset of labor and/or vaginal bleeding. This approach has reduced maternal morbidity rates, including less blood loss, fewer transfusion requirements and, intraoperative urologic injuries as well as improve fetal outcome.

Ultrasound evaluation, with grayscale and color Doppler imaging, is the recommended first-line modality for diagnosing PAS. Grayscale ultrasound features suggestive of placenta accreta include an inability to visualize the normal retroplacental clear zone, irregularity and attenuation of the uterine-bladder interface, retroplacental myometrial thickness, presence of intraplacental lacunar spaces, and bridging vessels between the placenta and bladder wall when using color Doppler. Magnetic resonance imaging (MRI) has been used to predict the depth of placental invasion, but it is expensive and often not immediately available.

Recently, a new imaging technique utilizing three-dimensional (3D)/four-dimensional (4D) volume rendering ultrasound (VRU) was proposed as a promising tool for the preoperative diagnosis of placenta previa accerta spectrum. By using "crystal vue" and "realistic vue" volume rendering mode, it could detect 11 out of 12 cases (91.6%) of PAS which was subsequently confirmed during surgery. Accordingly, The aim of this study is to examine the diagnostic performance of 3D/four-dimensional (4D) volume rendering ultrasound (VRU) for placenta previa accerta spectrum in correlation with the clinical (operative) and pathological findings.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04229953
Study type Observational
Source Mansoura University
Contact Hatem Abu Hashim, MD.FRCOG.PhD
Phone +20502300002
Email hatem_ah@hotmail.com
Status Not yet recruiting
Phase
Start date February 1, 2020
Completion date March 1, 2021

See also
  Status Clinical Trial Phase
Withdrawn NCT04927988 - Blood Components Changes by Using of Ringer's Lactated as Detergent In Autologous Blood Cell Transfusion N/A
Not yet recruiting NCT04525001 - MOGGE PAR Scores for Prediction of Outcomes of PAS
Completed NCT04427592 - New Conservative Technique for Placenta Accreta Spectrum N/A
Completed NCT04314791 - Accuracy of Placenta Accreta Index in Diagnosing Placenta Accreta Spectrum
Completed NCT06356493 - Prophylactic Occlusion Balloons of Both Internal Iliac Arteries in Caesarean Hysterectomy for PASD
Recruiting NCT06383923 - Risk Factors, Prognosis and Prediction Models for Placenta Accreta Without Prior Cesarean Section
Recruiting NCT05752513 - Early vs Late Bladder Dissection During CS Hysterectomy in Patients With PAS With Bladder Invasion N/A
Completed NCT05500404 - Diagnostic Accuracy of Placental Thickness in Lower Uterine Segment Measured By Ultrasound in Prediction of Placenta Accreta Spectrum in Patients With Placenta Previa. A Diagnostic Test Accuracy Study
Recruiting NCT05510076 - Evaluation of Different Surgical Approaches Used for Conservative Management of Placenta Accreta Spectrum in Sohag University Hospital
Not yet recruiting NCT05481606 - Cesarean Scar Pregnancy and Clinical Outcomes
Recruiting NCT04866888 - Placenta Accreta Spectrum Outcome After Uterine Conservation N/A